Amabile E, Fazio F, Martelli M, Petrucci M T
Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Azienda Policlinico Umberto I, Rome, Italy.
Leuk Res Rep. 2024 Nov 26;22:100491. doi: 10.1016/j.lrr.2024.100491. eCollection 2024.
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome) is a rare condition due to an underlying plasma cell neoplasm whose clinical presentation can be various so it could lead to delayed diagnosis and treatment. The pathogenesis of the syndrome is not well understood, and its therapy is adapted from other plasma cell disorders with the aim of alleviating symptoms, decreasing end-organ damage, improving quality of life and prolonging overall survival. We report a case of a 71 years-old woman who has been treated with continuous DRd (daratumumab, lenalidomide and dexamethasone) scheme.
POEMS综合征（多发性神经病、脏器肿大、内分泌病、M蛋白、皮肤改变综合征）是一种由潜在浆细胞肿瘤引起的罕见病症，其临床表现多样，可能导致诊断和治疗延迟。该综合征的发病机制尚不完全清楚，其治疗方法借鉴了其他浆细胞疾病，目的是缓解症状、减少终末器官损害、提高生活质量并延长总生存期。我们报告一例71岁女性患者，该患者接受了持续DRd（达雷妥尤单抗、来那度胺和地塞米松）方案治疗。
